IMPEL PHARMACEUTICALS INC·4

May 12, 4:41 PM ET

Kalb Michael Wayne 4

4 · IMPEL PHARMACEUTICALS INC · Filed May 12, 2023

Insider Transaction Report

Form 4
Period: 2023-05-10
Transactions
  • Award

    Stock Option (right to buy)

    2023-05-10+175,000175,000 total
    Exercise: $2.43Exp: 2033-05-10Common Stock (175,000 underlying)
  • Award

    Restricted Stock Units (RSUs)

    2023-05-10+47,50047,500 total
    Exp: 2033-05-10Common Stock (47,500 underlying)
Footnotes (3)
  • [F1]The option vests as to 25% of the total shares on May 10, 2024 and then 1/48th of the total shares vests on each monthly anniversary thereafter, subject to the reporting person's provision of service to the issuer on each vesting date.
  • [F2]Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
  • [F3]The RSUs vest as to 100% of the total shares on May 31, 2024, subject to the reporting person's continuation of employment on such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION